Tao Li Selected Research

Punctures

12/2024	Notoginsenoside R1 improves intestinal microvascular functioning in sepsis by targeting Drp1-mediated mitochondrial quality imbalance.
4/2024	4-phenylbutyric acid improves sepsis-induced cardiac dysfunction by modulating amino acid metabolism and lipid metabolism via Comt/Ptgs2/Ppara.
1/2024	Radix Sanguisorbae Improves Intestinal Barrier in Septic Rats via HIF-1 α/HO-1/Fe2+ Axis.
1/2023	Pericytes protect rats and mice from sepsis-induced injuries by maintaining vascular reactivity and barrier function: implication of miRNAs and microvesicles.
1/2023	Nano Parthenolide Improves Intestinal Barrier Function of Sepsis by Inhibiting Apoptosis and ROS via 5-HTR2A.
1/2023	VDAC2 malonylation participates in sepsis-induced myocardial dysfunction via mitochondrial-related ferroptosis.
1/2023	Extracellular histone H3 facilitates ferroptosis in sepsis through ROS/JNK pathway.
2/2022	Correlation analysis of the puncture-side bone cement/vertebral body volume ratio and bone cement leakage in the paravertebral vein in vertebroplasty.
1/2021	Synergetic Effect of 4-Phenylbutyric Acid in Combination with Cyclosporine A on Cardiovascular Function in Sepsis Rats via Inhibition of Endoplasmic Reticulum Stress and Mitochondrial Permeability Transition Pore Opening.
1/2021	Mesenchymal stem cell-derived microvesicles improve intestinal barrier function by restoring mitochondrial dynamic balance in sepsis rats.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tao Li Research Topics

Disease

512	Neoplasms (Cancer) 05/2024 - 04/2002
145	Infections 05/2024 - 01/2004
132	Inflammation (Inflammations) 05/2024 - 10/2006
106	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 01/2003
95	Neoplasm Metastasis (Metastasis) 05/2024 - 08/2002
74	Schizophrenia (Dementia Praecox) 03/2024 - 11/2003
71	Hypoxia (Hypoxemia) 04/2024 - 01/2006
70	Hemorrhagic Shock 01/2023 - 11/2005
60	Carcinogenesis 03/2024 - 01/2003
54	Wounds and Injuries (Trauma) 03/2024 - 01/2009
52	Sepsis (Septicemia) 12/2024 - 07/2003
49	Pain (Aches) 05/2024 - 08/2010
49	COVID-19 01/2024 - 01/2020
49	Shock 01/2022 - 11/2005
48	Fibrosis (Cirrhosis) 04/2024 - 01/2004
47	Hemorrhage 04/2024 - 02/2004
41	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 03/2006
41	Breast Neoplasms (Breast Cancer) 04/2024 - 12/2002
41	Reperfusion Injury 04/2024 - 12/2008
39	Stomach Neoplasms (Stomach Cancer) 04/2024 - 10/2004
37	Carcinoma (Carcinomatosis) 10/2023 - 12/2002
36	Ischemia 12/2024 - 12/2008
35	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 06/2010
34	Brain Injuries (Brain Injury) 01/2023 - 06/2014
31	Glioma (Gliomas) 12/2023 - 03/2011
31	Stroke (Strokes) 11/2023 - 02/2004
29	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 12/2013
29	Body Weight (Weight, Body) 12/2023 - 08/2002
28	Necrosis 05/2024 - 04/2006
28	Myocardial Infarction 04/2024 - 01/2005
28	Lung Neoplasms (Lung Cancer) 02/2024 - 08/2004
27	Alzheimer Disease (Alzheimer's Disease) 10/2023 - 01/2004
26	Obesity 02/2024 - 01/2015
25	Hypertension (High Blood Pressure) 03/2024 - 08/2002
24	Infarction (Infarctions) 04/2024 - 01/2005
23	Liver Neoplasms (Liver Cancer) 12/2023 - 07/2003
22	Ischemic Stroke 02/2024 - 07/2012
21	Brain Edema (Cerebral Edema) 01/2022 - 10/2011
20	Chronic Hepatitis B 05/2024 - 01/2012
20	Insulin Resistance 05/2024 - 09/2004
20	Neuroinflammatory Diseases 01/2024 - 11/2009
20	Type 2 Diabetes Mellitus (MODY) 11/2023 - 07/2012
19	Esophageal Squamous Cell Carcinoma 01/2023 - 03/2011
19	Osteoarthritis 01/2023 - 01/2010
18	Osteoporosis 03/2024 - 09/2013
18	Mitochondrial Diseases (Mitochondrial Disease) 02/2024 - 09/2008
18	Virus Diseases (Viral Diseases) 02/2024 - 08/2009
18	Melanoma (Melanoma, Malignant) 01/2024 - 08/2012
18	Glioblastoma (Glioblastoma Multiforme) 12/2023 - 08/2015
18	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2023 - 09/2008
18	Malaria 12/2022 - 01/2003

Drug/Important Bio-Agent (IBA)

205	Proteins (Proteins, Gene)FDA Link 05/2024 - 08/2002
127	Biomarkers (Surrogate Marker)IBA 04/2024 - 07/2003
67	Messenger RNA (mRNA)IBA 01/2024 - 07/2003
66	MicroRNAs (MicroRNA)IBA 12/2023 - 04/2012
58	CytokinesIBA 03/2024 - 07/2003
50	Therapeutic UsesIBA 04/2024 - 03/2000
48	RNA (Ribonucleic Acid)IBA 05/2024 - 03/2013
44	Long Noncoding RNAIBA 12/2024 - 01/2014
43	LipopolysaccharidesIBA 12/2024 - 08/2009
40	VaccinesIBA 01/2024 - 07/2004
39	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 04/2002
37	LipidsIBA 05/2024 - 05/2003
36	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 09/2004
33	Oxygen (Dioxygen)IBA 11/2023 - 01/2009
32	Antipsychotic Agents (Antipsychotics)IBA 01/2024 - 01/2007
31	Hemoglobins (Hemoglobin)IBA 01/2024 - 01/2009
31	EnzymesIBA 01/2024 - 01/2004
31	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024 - 09/2008
30	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2020
29	Peptides (Polypeptides)IBA 11/2023 - 01/2003
28	AntioxidantsIBA 03/2024 - 05/2013
27	CalciumIBA 11/2023 - 11/2005
25	Small Interfering RNA (siRNA)IBA 01/2023 - 01/2012
24	Indicators and Reagents (Reagents)IBA 04/2024 - 03/2015
23	Neuroprotective AgentsIBA 01/2023 - 01/2013
22	CateninsIBA 02/2024 - 11/2014
22	Antiviral Agents (Antivirals)IBA 01/2024 - 04/2006
22	Caspase 3 (Caspase-3)IBA 11/2023 - 01/2011
21	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 05/2011
21	rho-Associated KinasesIBA 10/2022 - 06/2006
20	LigandsIBA 12/2023 - 12/2004
20	Interleukin-6 (Interleukin 6)IBA 08/2022 - 12/2005
19	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 01/2005
18	CollagenIBA 05/2024 - 05/2006
18	Cisplatin (Platino)FDA LinkGeneric 02/2024 - 04/2013
18	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2023 - 12/2005
17	AntibodiesIBA 05/2024 - 01/2015
17	InterferonsIBA 04/2024 - 04/2006

Therapy/Procedure

234	Therapeutics 05/2024 - 07/2003
101	Drug Therapy (Chemotherapy) 05/2024 - 03/2000
57	Radiotherapy 04/2024 - 03/2006
41	Immunotherapy 04/2024 - 01/2004
36	Ligation 12/2024 - 02/2013
29	Punctures 12/2024 - 10/2010
29	Resuscitation 01/2023 - 03/2008
28	Length of Stay 01/2024 - 01/2005
25	Chemoradiotherapy 08/2023 - 06/2010
22	Aftercare (After-Treatment) 05/2023 - 02/2007
19	Neoadjuvant Therapy 03/2024 - 02/2011